New blood test could spot liver cancer sooner
NCT ID NCT07319299
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a new blood test score, called GAAD, can detect liver cancer earlier in people with chronic liver disease. The GAAD score combines a person's gender, age, and two blood markers (AFP and PIVKA-II). Researchers will compare the GAAD score to standard ultrasound and AFP tests in 2,100 participants over 24 months. The goal is to see if the GAAD score improves detection and reduces false alarms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- GAAD score (blood test combining gender, age, AFP, and PIVKA-II)
- What this could lead to
- If successful, the GAAD score could become a standard, more accurate blood test to catch liver cancer early in people with chronic liver disease.
- What could go wrong
- This is a diagnostic study, not a treatment. The GAAD score may not prove significantly better than current methods, and results may not apply outside the specific patient group studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL-RELATED LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Medicine Siriraj Hospital
Bangkoknoi, Bangkok, 10700, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Weight-Loss surgery rewire the Liver's energy engine?
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Could a yellow tinge predict dangerous hospital infections?
- Muscle quality on MRI may foretell liver transplant success
- Could a new drug tame fatty liver disease? early trial aims to find out
- Liver scan changes may foretell deadly complications